Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 250 of 5804
-
Can special glasses or eyedrops stop kids' eyesight from getting worse?
Disease control Recruiting nowTo date, randomized trials of low-concentration atropine eyedrops and specially designed spectacle lenses to slow the progression of myopia are limited in number and results are inconsistent in non-Asian children. Although results of some recent randomized clinical trials outsid…
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug cocktail aims to outsmart lung cancer resistance
Disease control Not yet recruitingProtocol Title A Study to Evaluate ANS014004 in Combination with EGFR-TKI in Patients with EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer The main purpose of this research study is to Find a safe and tolerable dose of two investigational drugs…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Promising new combo targets tough lymphoma in older adults
Disease control Not yet recruitingThis single-arm, interventional phase 2 study is designed to evaluate whether the inclusion of mosunetuzumab subcutaneous and polatuzumab vedotin (Mosun-Pola) to a split-dose CHP chemotherapy backbone will improve outcomes for elderly patients with a new diagnosis of diffuse larg…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New transplant method aims to reduce dangerous side effects in blood cancer patients
Disease control TerminatedThis study will evaluate whether processing blood stem cell transplants using an investigational device (the CliniMACS system) results in fewer complications for patients who undergo transplant to treat a blood malignancy (cancer) or blood disorder. The CliniMACS system will be …
Phase: PHASE2 • Sponsor: Guenther Koehne • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New trial aims to stop oral lesions from turning into cancer
Disease control Not yet recruitingThe goal of this clinical trial is to optimize treatment strategies for patients with p53-mutant oral epithelial dysplasia (OED) and early-stage oral squamous cell carcinoma (OSCC). The main question it aims to answer is what the most optimal treatment is at each diagnostic stage…
Phase: NA • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New triple-drug attack targets rare blood cancer
Disease control Not yet recruitingThis is a phase II (2 parts), open-label, single arm, multicenter study to evaluate the efficacy and safety of nemtabrutinib in combination with bortezomib and rituximab
Phase: PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to control breast cancer brain metastases
Disease control Not yet recruitingThis is a prospective, open-label, exploratory clinical trial designed to evaluate the efficacy and safety of brain radiotherapy combined with dalpiciclib and endocrine therapy in HR-positive/HER2-negative advanced breast cancer patients with brain metastases. A total of 46 patie…
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug cocktail takes aim at tough lung cancer
Disease control Not yet recruitingThis is a Phase Ib/II, open-label clinical study designed to evaluate the safety, tolerability, preliminary anti-tumor activity, recommended Phase 2 dose (RP2D), pharmacokinetic (PK) characteristics, and immunogenicity of DXC006 in combination with an immune checkpoint inhibitor …
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Tough-to-Treat myeloma: phase 3 trial launches
Disease control Not yet recruitingThis study is a randomized, open-label, multicenter Phase III clinical trial involving patients with relapsed/refractory multiple myeloma. The estimated total sample size is 260 cases, who will be randomly assigned in a 1:1 ratio to the test group and the control group. The prima…
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy aims to tackle advanced liver cancer
Disease control Not yet recruitingTo provide evidence-based medical evidence for the optimized combination strategy of local and systemic therapies.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New cocktail of drugs takes on Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study is a randomized, open-label, controlled, multicenter Phase II trial conducted in patients with advanced HER2-positive breast cancer, aimed at evaluating the efficacy and safety of paclitaxel polymer micelles for injection combined with trastuzumab and adalimumab versus…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a Triple-Drug cocktail beat long COVID?
Disease control Not yet recruitingThe purpose of this research study is to test if the combination of three drugs, valacyclovir, celecoxib, and Paxlovid will decrease the symptoms of Long COVID in adults compared to a placebo (this does not contain the medications).
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Gut bacteria boost may resensitize kidney tumors to immunotherapy
Disease control Recruiting nowThe combination of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) has significantly improved clinical outcomes in patients with advanced renal cell carcinoma (RCC). However, 40%-60% of patients still develop primary or acquired resistance. For those wit…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat breast cancer before surgery
Disease control Not yet recruitingThis is a phase II, single-arm, prospective exploratory study to evaluate the efficacy and safety of neoadjuvant dalpiciclib (a CDK4/6 inhibitor) plus an aromatase inhibitor (AI) followed by SHR-A1811 (an anti-HER2 antibody-drug conjugate) in patients with intermediate-to-high ri…
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Promising drug cocktail aims to shrink aggressive nasal tumors before surgery
Disease control Not yet recruitingT4 stage sinonasal adenoid cystic carcinoma (SNACC) is a rare but aggressive cancer in the nasal cavity and sinuses. These tumors often invade the skull base, eye socket, or brain covering (dura), making complete surgical removal difficult and carrying a high risk of recurrence e…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Artificial intelligence could spot hidden cancer spread before It's too late
Knowledge-focused Not yet recruitingEarly detection and timely intervention of distant metastasis are essential for improving the prognosis of patients with malignant tumors. However, current clinical methods have notable limitations. Conventional imaging can only detect macroscopic metastatic lesions, failing to s…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to improve leukemia treatment before transplant
Disease control Recruiting nowThis clinical trial aims to compare the efficacy and safety of venetoclax-based consolidation therapy versus conventional consolidation chemotherapy (intermediate/high-dose cytarabine) in newly diagnosed adult patients with intermediate-risk acute myeloid leukemia (AML). Particip…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Pig liver scaffold may speed healing of stubborn diabetic wounds
Disease control Recruiting nowThis study is designed to evaluate whether the Miro3D Wound Matrix, when used in addition to standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and may be difficult to …
Phase: NA • Sponsor: Reprise Biomedical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Personalized navigation may boost cancer screening in high-risk communities
Prevention Not yet recruitingThis study will evaluate whether a precision navigation intervention can help community residents at high risk for cancer complete recommended cancer screening. The study will be conducted in communities participating in an urban cancer screening program in China. Eligible parti…
Phase: NA • Sponsor: Hunan Cancer Hospital • Aim: Prevention
Last updated Jul 10, 2026 00:00 UTC
-
Could a daily glass of kefir during pregnancy ward off gestational diabetes?
Prevention Not yet recruitingPregnancy is a critical window for metabolic health, and early changes in blood sugar regulation can increase the risk of gestational diabetes mellitus (GDM), which affects both maternal and infant health. At the same time, the maternal gut microbiome changes throughout pregnancy…
Phase: NA • Sponsor: University of New Brunswick • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC